Advancements in transurethral management of urethral stricture disease
- PMID: 34175872
- DOI: 10.1097/MOU.0000000000000913
Advancements in transurethral management of urethral stricture disease
Abstract
Purpose of review: To explore and report the recent evolution of transurethral management of urethral stricture disease.
Recent findings: In recent years, new promising techniques in the transurethral management of urethral stricture disease have emerged including adjuvant therapies to direct vision internal urethrotomy, regenerative therapy with buccal mucosa cells and minimally invasive transurethral urethroplasty procedures that avoid skin incisions.
Summary: Although further work is needed, the expanding field of transurethral therapies for urethral stricture disease demonstrates early promising results through a variety of modalities.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Pansadoro V, Emilliozi P. Internal urethrotomy in the management of anterior urethral strictures: Long term follow-up. J Urol 1996; 156:73–75.
-
- Heyns CF, Steenkamp JW, De Kock ML, et al. Treatment of male urethral strictures: is repeated dilation or internal urethrotomy useful? J Urol 1998; 160:356–358.
-
- Simsek A, Aldamanhori R, Chapple CR, et al. Overcoming scarring in the urethra: challenges for tissue engineering. Asian J Urol 2018; 5:69–77.
-
- Park JJ, Kuo TL, Chapple CR. Mitomycin C in the treatment of anterior urethral strictures. Nat Rev Urol 2018; 15:717–718.
-
- Farrell MR, Lawrenz CW, Levine LA. Internal urethrotomy with intralesional mitomycin C: an effective option for Endoscopic management of recurrent bulbar and bulbomembranous urethral strictures. Urology 2017; 110:223–227.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
